Methylepoxyproscillaridin
| Code | Size | Price |
|---|
| TAR-T33352-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Methylepoxyproscillaridin is a semisynthetic cardiac glycoside.
CAS:
116387-44-1
Formula:
C31H44O9
Molecular Weight:
560.684
Purity:
0.98
SMILES:
[H][C@@]12CCC34OC3[C@H](CC[C@]4(C)[C@@]1([H])CC[C@]1(C)[C@H](CC[C@]21O)c1ccc(=O)oc1)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](OC)[C@H]1O
References
Bonelli J, Magometschnig D, Gazo F. Hemodynamic effect of methylepoxyproscillaridin (P35) in patients with congestive myocardiopathy. Int J Clin Pharmacol Ther Toxicol. 1988 May;26(5):243-5. PubMed PMID: 3410600.
Bonelli J, Waginger W, Gazo F. The bioavailability of methylepoxyproscillaridin (P35): a new semisynthetic cardiac glycoside. Int J Clin Pharmacol Ther Toxicol. 1988 Jun;26(6):297-9. PubMed PMID: 3410606.